IL141032A0 - Estradiol-containing patch for transdermal administration of hormones - Google Patents

Estradiol-containing patch for transdermal administration of hormones

Info

Publication number
IL141032A0
IL141032A0 IL14103299A IL14103299A IL141032A0 IL 141032 A0 IL141032 A0 IL 141032A0 IL 14103299 A IL14103299 A IL 14103299A IL 14103299 A IL14103299 A IL 14103299A IL 141032 A0 IL141032 A0 IL 141032A0
Authority
IL
Israel
Prior art keywords
estradiol
hormones
transdermal administration
containing patch
patch
Prior art date
Application number
IL14103299A
Other languages
English (en)
Original Assignee
Lts Lohmann Theraphie Systeme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Theraphie Systeme filed Critical Lts Lohmann Theraphie Systeme
Publication of IL141032A0 publication Critical patent/IL141032A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IL14103299A 1998-07-29 1999-07-16 Estradiol-containing patch for transdermal administration of hormones IL141032A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19834006A DE19834006A1 (de) 1998-07-29 1998-07-29 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen
PCT/EP1999/005084 WO2000006130A1 (de) 1998-07-29 1999-07-16 Estradiolhaltiges pflaster zur transdermalen applikation von hormonen

Publications (1)

Publication Number Publication Date
IL141032A0 true IL141032A0 (en) 2002-02-10

Family

ID=7875612

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14103299A IL141032A0 (en) 1998-07-29 1999-07-16 Estradiol-containing patch for transdermal administration of hormones

Country Status (14)

Country Link
EP (1) EP1100478A1 (ja)
JP (1) JP2002521426A (ja)
KR (1) KR20010072071A (ja)
CN (1) CN1310615A (ja)
AR (1) AR019948A1 (ja)
AU (1) AU762589B2 (ja)
BR (1) BR9912688A (ja)
CA (1) CA2338861A1 (ja)
DE (1) DE19834006A1 (ja)
IL (1) IL141032A0 (ja)
PL (1) PL345696A1 (ja)
TR (1) TR200100290T2 (ja)
WO (1) WO2000006130A1 (ja)
ZA (1) ZA200100721B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005047906A (ja) * 2003-07-16 2005-02-24 Taisho Pharmaceut Co Ltd 外用消炎鎮痛剤組成物
KR100689534B1 (ko) * 2005-05-18 2007-03-02 삼성전자주식회사 휴대 단말기

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (ja) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
AU692504B2 (en) * 1993-12-27 1998-06-11 Akzo Nobel N.V. Percutaneously absorbable preparation
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
KR20010072071A (ko) 2001-07-31
EP1100478A1 (de) 2001-05-23
BR9912688A (pt) 2001-11-27
CN1310615A (zh) 2001-08-29
DE19834006A1 (de) 2000-02-24
AR019948A1 (es) 2002-03-27
PL345696A1 (en) 2002-01-02
CA2338861A1 (en) 2000-02-10
ZA200100721B (en) 2002-05-27
AU5284299A (en) 2000-02-21
WO2000006130A1 (de) 2000-02-10
TR200100290T2 (tr) 2001-07-23
AU762589B2 (en) 2003-06-26
JP2002521426A (ja) 2002-07-16

Similar Documents

Publication Publication Date Title
PL345695A1 (en) Estradiol-containing patch for transdermal administration of hormones
AU1585601A (en) Transdermal administration of huperzine
IL138509A0 (en) Topical transdermal anesthetic formulation
GB2328375B (en) Transdermal patch
AU7601998A (en) Composition and methods for transdermal delivery of acid labile drugs
AU3654697A (en) Transdermal application of naturally occurring steriod hormones
NO980126D0 (no) Plaster-formulering for perkantal administrering av fenantyl
AU2001231189A1 (en) Transdermal anesthetic and vasodilator composition and methods for topical administration
IL127189A0 (en) Compositions methods and devices for the transdermal delivery of drugs
NZ331904A (en) Transdermal patch for administration of drugs through a controlled and sustained release system
EP1117357A4 (en) METHODS AND DEVICES FOR IMPROVING THE ADMINISTRATION OF PHARMACEUTICALLY ACTIVE COMPOUNDS
AU2001277671A1 (en) Apparatus and applicator patch for transdermal substance delivery
GB0013337D0 (en) Transdermal patch for nonsteroidal antiinflammatory drug(s)
AU6017698A (en) Fillable patch for dermal or transdermal delivery
EP1280485A4 (en) TRANSDERMAL STAMP FOR IMPROVED MEDICINE
EP0941039A4 (en) TRANSDERMAL ADMINISTRATION OF 7alpha-METHYL-19-NORTESTOSTERONE ("MENT")
IL140434A0 (en) Transdermal therapeutic system containing hormones and crystallization inhibitors
AU1262501A (en) Compositions for transdermal and transmucosal administration of therapeutic agents
HUP0000445A3 (en) Flat transdermal medicated self-adhesive patch
AU3869399A (en) Transdermal administration of fenoldopam
AU1068101A (en) Transdermal administration of reboxetine
AU5155198A (en) Method and composition for transdermal administration of pharmacologic agent
GB9918735D0 (en) Transdermal patches
AU6605100A (en) Method and pharmaceutical composition for parenteral administration of iron
PL345696A1 (en) Estradiol-containing patch for transdermal administration of hormones